SCHEMBL15980422

SCHEMBL15980422

CCCCc1ccc(-c2ccc(C#Cc3c(F)cc(CC)cc3F)cc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.46
TSHR P16473 1/20 0.46
RARB P10826 9/20 0.42
RARA P10276 2/20 0.42
RARG P13631 1/20 0.42
GPR84 Q9NQS5 1/20 0.37
PTPN11 Q06124 1/20 0.37
PTPRO Q16827 1/20 0.37
ALDH1A1 P00352 2/20 0.35
MEN1 O00255 1/20 0.35
MAPT P10636 1/20 0.35
MTOR P42345 1/20 0.35
KMT2A Q03164 1/20 0.35
AKR1C2 P52895 1/20 0.35
AKR1C1 Q04828 1/20 0.35
ESR1 P03372 2/20 0.35
ADRA2A P08913 2/20 0.35
ADORA3 P0DMS8 2/20 0.35
TACR2 P21452 2/20 0.35
SLC6A2 P23975 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28289825 0.96 HSD17B10 (0.51) HSD17B10TSHRRARBRARARARG
SCHEMBL8755306 0.94 TSHR (0.42) HSD17B10TSHRRARBRARARARG
SCHEMBL14846051 0.94 TSHR (0.48) HSD17B10TSHRRARBRARARARG
SCHEMBL14365592 0.92 TSHR (0.46) HSD17B10TSHRRARBRARARARG
SCHEMBL15980421 0.92 TSHR (0.46) HSD17B10TSHRRARBRARARARG
SCHEMBL15980423 0.92 HSD17B10 (0.52) HSD17B10TSHRRARBRARARARG
SCHEMBL8755849 0.92 ACACB (0.38) HSD17B10TSHRRARBRARARARG
SCHEMBL8755106 0.90 HSD17B10 (0.48) HSD17B10TSHRRARBRARARARG
SCHEMBL14773018 0.89 TSHR (0.46) HSD17B10TSHRRARBRARARARG
SCHEMBL8978920 0.89 PTPN11 (0.38) HSD17B10TSHRRARBRARARARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240228878-A1 COMPOUND, LIQUID CRYSTAL COMPOSITION, AS WELL AS LIQUID CRYSTAL DISPLAY ELEMENT, SENSOR, LIQUID CRYSTAL LENS, OPTICAL COMMUNICATION EQUIPMENT, AND ANTENNA EACH USING THE SAME DIC CORPORATION (JP) 2024-07-11 US disclosed
US-20240228878-A1 COMPOUND, LIQUID CRYSTAL COMPOSITION, AS WELL AS LIQUID CRYSTAL DISPLAY ELEMENT, SENSOR, LIQUID CRYSTAL LENS, OPTICAL COMMUNICATION EQUIPMENT, AND ANTENNA EACH USING THE SAME DIC CORPORATION (JP) 2024-07-11 US disclosed
US-9493703-B2 Liquid crystal medium and high-frequency components comprising same MERCK PATENT GMBH (DE) 2016-11-15 US disclosed
US-9493703-B2 Liquid crystal medium and high-frequency components comprising same MERCK PATENT GMBH (DE) 2016-11-15 US disclosed
US-20140239227-A1 LIQUID CRYSTAL MEDIUM AND HIGH-FREQUENCY COMPONENTS COMPRISING SAME MERCK PATENT GMBH (DE) 2014-08-28 US disclosed
US-20140239227-A1 LIQUID CRYSTAL MEDIUM AND HIGH-FREQUENCY COMPONENTS COMPRISING SAME MERCK PATENT GMBH (DE) 2014-08-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240228878-A1 COMPOUND, LIQUID CRYSTAL COMPOSITION, AS WELL AS LIQUID CRYSTAL DISPLAY ELEMENT, SENSOR, LIQUID CRYSTAL LENS, OPTICAL COMMUNICATION EQUIPMENT, AND ANTENNA EACH USING THE SAME TTI2, CCT4, CCT2 HSD17B10 4365/4885TSHR 196/4885RARB 1680/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.